1. Antonetti DA, Klein R, Gardner TW: Diabetic retinopathy. N Engl J Med 2012;366:1227-1239
2. Yonemura D, Aoki T, Tsuzuki K: Electroretinogram in diabetic retinopathy. Arch Ophthalmol- Chic 1962;68:19-24
3. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW: Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. The Journal of clinical investigation 1998;102:783-791
4. Li Q, Zemel E, Miller B, Perlman I: Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Experimental eye research 2002;74:615- 625
5. Di Leo M, Falsini B, Caputo S, Ghirlanda G, Porciatti V, Greco A: Spatial frequency-selective losses with pattern electroretinogram in type 1 (insulin-dependent) diabetic patients without retinopathy. Diabetologia 1990;33:726-730
6. Holopigian K, Seiple W, Lorenzo M, Carr R: A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy. Investigative ophthalmology & visual science 1992;33:2773-2780
7. Hammes H-P: Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond. Diabetologia 2018;61:29-38
8. Okabe K, Kobayashi S, Yamada T, Kurihara T, Tai-Nagara I, Miyamoto T, Mukouyama Y-s, Sato TN, Suda T, Ema M: Neurons limit angiogenesis by titrating VEGF in retina. Cell 2014;159:584-596
9. Giardino I, Fard AK, Hatchell DL, Brownlee M: Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 1998;47:1114-1120
10. Roy S, Kern TS, Song B, Stuebe C: Mechanistic insights into pathological changes in the diabetic retina: implications for targeting diabetic retinopathy. The American journal of pathology 2017;187:9-19
11. Willis JR, Doan QV, Gleeson M, Haskova Z, Ramulu P, Morse L, Cantrell RA: Vision-related functional burden of diabetic retinopathy across severity levels in the United States. JAMA ophthalmology 2017;135:926-932
12. Cusato K, Bosco A, Linden R, Reese BE: Cell death in the inner nuclear layer of the retina is modulated by BDNF. Developmental brain research 2002;139:325-330
13. Almeida R, Manadas B, Melo C, Gomes J, Mendes C, Graos M, Carvalho R, Carvalho A, Duarte C: Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell death and differentiation 2005;12:1329
14. Seki M, Tanaka T, Nawa H, Usui T, Fukuchi T, Ikeda K, Abe H, Takei N: Involvement of brain- derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 2004;53:2412-2419
15. Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, Strother JM: Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes 1998;47:815-820
16. Ola MS, Nawaz MI, El-Asrar AA, Abouammoh M, Alhomida AS: Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats. Cellular and molecular neurobiology 2013;33:359-367
17. Abdel-Maksoud SM, Hassanein SI, Gohar NA, Attia SM, Gad MZ: Investigation of brain- derived neurotrophic factor (BDNF) gene expression in hypothalamus of obese rats: Modulation by omega-3 fatty acids. Nutritional neuroscience 2017;20:443-448
18. Bak DH, Zhang E, Yi M-H, Kim D-K, Lim K, Kim J-J, Kim DW: High ω3-polyunsaturated fatty acids in fat-1 mice prevent streptozotocin-induced Purkinje cell degeneration through BDNF- mediated autophagy. Scientific reports 2015;5:15465
19. Bousquet M, Saint-Pierre M, Julien C, Salem Jr N, Cicchetti F, Calon F: Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson’s disease. The FASEB Journal 2008;22:1213-1225
20. Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem Jr N, Ashe KH, Frautschy SA, Cole GM: Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004;43:633-645
21. Nagaya M, Ueno S, Kominami T, Nakanishi A, Koyasu T, Kondo M, Furukawa T, Terasaki H: Pikachurin protein required for increase of cone electroretinogram b-wave during light adaptation. PLoS One 2015;10:e0128921
22. Ohba M, Saeki K, Koga T, Okuno T, Kobayashi Y, Yokomizo T: Profiling of bioactive lipids in different dendritic cell subsets using an improved multiplex quantitative LC-MS/MS method. Biochemical and biophysical research communications 2018;504:562-568
23. Hirakata T, Lee H-C, Ohba M, Saeki K, Okuno T, Murakami A, Matsuda A, Yokomizo T: Dietary ω-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating Th2 immune responses. The FASEB Journal 2018;33:3392-3403
24. Kaneko H, Ye F, Ijima R, Kachi S, Kato S, Nagaya M, Higuchi A, Terasaki H: Histamine receptor h4 as a new therapeutic target for choroidal neovascularization in age-related macular degeneration. Br J Pharmacol 2014;171:3754-3763
25. Ihnat M, Thorpe J, Kamat C, Szabo C, Green D, Warnke L, Lacza Z, Cselenyak A, Ross K, Shakir S: Reactive oxygen species mediate a cellular ‘memory’of high glucose stress signalling. Diabetologia 2007;50:1523-1531
26. Miyake S, Kobayashi S, Tsubota K, Ozawa Y: Phase II enzyme induction by a carotenoid, lutein, in a PC12D neuronal cell line. Biochemical and biophysical research communications 2014;446:535-540
27. Kurihara T, Ozawa Y, Nagai N, Shinoda K, Noda K, Imamura Y, Tsubota K, Okano H, Oike Y, Ishida S: Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes 2008;57:2191-2198
28. Ano Y, Ohya R, Kita M, Taniguchi Y, Kondo K: Theaflavins Improve Memory Impairment and Depression-Like Behavior by Regulating Microglial Activation. Molecules 2019;24:467
29. Liu MH, Yuan C, He J, Tan TP, Wu SJ, Fu HY, Liu J, Yu S, Chen YD, Le QF, Tian W, Hu HJ, Zhang Y, Lin XL: Resveratrol protects PC12 cells from high glucose-induced neurotoxicity via PI3K/Akt/FoxO3a pathway. Cell Mol Neurobiol. 2015;35(4):513-22
30. Hao M, Li Y, Lin W, Xu Q, Shao N, Zhang Y, Kuang H: Estrogen prevents high-glucose- induced damage of retinal ganglion cells via mitochondrial pathway. Graefes Arch Clin Exp Ophthalmol. 2015;253(1):83-90
31. Ansari S, Djalali M, Mohammadzadeh N, Mohammadzadeh Honarvar N, Mazaherioun M, Zarei M, Gholampour Z, Javanbakht M: Assessing the effect of omega-3 fatty acids supplementation on serum BDNF (brain derived neurotrophic factor) in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Int Res J Appl Basic Sci 2016;10:380-383
32. Yuen N, Anderson SE, Glaser N, Tancredi DJ, O'Donnell ME: Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis. Diabetes 2008;57:2588-2594
33. Behl T, Kotwani A: Omega‐3 fatty acids in prevention of diabetic retinopathy. Journal of Pharmacy and Pharmacology 2017;69:946-954
34. Dong Y, Pu K, Duan W, Chen H, Chen L, Wang Y: Involvement of Akt/CREB signaling pathways in the protective effect of EPA against interleukin-1β-induced cytotoxicity and BDNF down-regulation in cultured rat hippocampal neurons. BMC neuroscience 2018;19:52
35. Connor KM, SanGiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A, Hong S, Pravda EA, Majchrzak S, Carper D: Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nature medicine 2007;13:868
36. Biessels G-J, Cristino NA, Rutten G-J, Hamers FP, Erkelens DW, Gispen WH: Neurophysiological changes in the central and peripheral nervous system of streptozotocin- diabetic rats: course of development and effects of insulin treatment. Brain 1999;122:757-768
37. Sheikh-Ali M1, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care 2008;31(4):643-7
38. Lo W, O'Donnell M, Tancredi D, Orgain M, Glaser N: Diabetic ketoacidosis in juvenile rats is associated with reactive gliosis and activation of microglia in the hippocampus. Pediatr Diabetes 2016;17(2):127-39
39. Glaser N, Anderson S, Leong W, Tancredi D, O'Donnell M: Cognitive dysfunction associated with diabetic ketoacidosis in rats. Neurosci Lett 2012;510(2):110-4
40. Glaser N, Ngo C, Anderson S, Yuen N, Trifu A, O'Donnell M: Effects of hyperglycemia and effects of ketosis on cerebral perfusion, cerebral water distribution, and cerebral metabolism. Diabetes 2012;61(7):1831-7
41. Serhan C. Pro-resolving lipid mediators are leads for resolution physiology. Nature. nature; 2014;510(7503):92–101
42. Endo J, Sano M, Isobe Y, Fukuda K, Kang JX, Arai H, Arita M: 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload–induced maladaptive cardiac remodeling. Journal of Experimental Medicine 2014;211:1673-1687
43. Sapieha P, Chen J, Stahl A, Seaward M, Favazza T, Juan A, Hatton C, Joyal J, Krah N, Dennison RJ: Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice. Nutrition & diabetes 2012;2:e36
44. Ibrahim AS, Elshafey S, Sellak H, Hussein KA, El-Sherbiny M, Abdelsaid M, Rizk N, Beasley S, Tawfik AM, Smith SB: A lipidomic screen of hyperglycemia-treated HRECs links 12/15- Lipoxygenase to microvascular dysfunction during diabetic retinopathy via NADPH oxidase. Journal of lipid research 2015;56:599-611
45. Othman A, Ahmad S, Megyerdi S, Mussell R, Choksi K, Maddipati KR, Elmarakby A, Rizk N, Al-Shabrawey M: 12/15-Lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: contribution of NADPH oxidase. PloS one 2013;8:e57254
46. Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & pharmacotherapy 2002;56:365-379
47. Simopoulos AP: The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Experimental biology and medicine 2008;233:674-688
48. Sakai H, Tani Y, Shirasawa E, Shirao Y, Kawasaki K: Development of Electroretinographic Alterations in Streptozotocin-lnduced Diabetes in Rats. Ophthalmic research 1995;27:57-63
49. Neschen S, Morino K, Dong J, Wang-Fischer Y, Cline GW, Romanelli AJ, Rossbacher JC, Moore IK, Regittnig W, Munoz DS: n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator–activated receptor-α–dependent manner. Diabetes 2007;56:1034-1041
50. Roy MS, Janal MN: High caloric and sodium intakes as risk factors for progression of retinopathy in type 1 diabetes mellitus. Arch Ophthalmol-Chic 2010;128:33-39
51. Baumeier C, Kaiser D, Heeren J, Scheja L, John C, Weise C, Eravci M, Lagerpusch M, Schulze G, Joost H-G: Caloric restriction and intermittent fasting alter hepatic lipid droplet proteome and diacylglycerol species and prevent diabetes in NZO mice. Biochimica et Biophysica Acta (BBA)- Molecular and Cell Biology of Lipids 2015;1851:566-576
52. Kaviarasan K, Jithu M, Mulla MA, Sharma T, Sivasankar S, Das UN, Angayarkanni N: Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance are potential risk factors for diabetic retinopathy. Metabolism 2015;64:958-966
53. El-Asrar A, Ahmed M, Nawaz MI, Siddiquei MM, Al-Kharashi AS, Kangave D, Mohammad G: High-mobility group box-1 induces decreased brain-derived neurotrophic factor-mediated neuroprotection in the diabetic retina. Mediators of inflammation 2013;2013
54. El-Asrar AMA, Mohammad G, De Hertogh G, Nawaz MI, Van Den Eynde K, Siddiquei MM, Struyf S, Opdenakker G, Geboes K: Neurotrophins and neurotrophin receptors in proliferative diabetic retinopathy. PLoS One 2013;8:e65472
55. Busik JV, Mohr S, Grant MB: Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 2008;57(7):1952-65.
56. Aranda J, Motiejunaite R, Im E, Kazlauskas A: Diabetes disrupts the response of retinal endothelial cells to the angiomodulator lysophosphatidic acid. Diabetes 2012;61(5):1225-33
57. Xie L, Zhu X, Hu Y, Li T, Gao Y, Shi Y, Tang S: Mitochondrial DNA oxidative damage triggering mitochondrial dysfunction and apoptosis in high glucose-induced HRECs. Invest Ophthalmol Vis Sci 2008;49(9):4203-9
58. Safi SZ, Qvist R, Yan GO, Ismail IS: Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial cells. BMC Med Genomics 2014;7:29
59. Lee YJ, Kim M, Lee JY, Jung SH, Jeon HY, Lee SA, Kang S, Han ET, Park WS, Hong SH, Kim YM, Ha KS: The benzodiazepine anesthetic midazolam prevents hyperglycemia-induced microvascular leakage in the retinas of diabetic mice. FASEB J 2018:fj201800014RR
60. Coughlin BA, Feenstra DJ, Mohr S: Müller cells and diabetic retinopathy. Vision Res 2017;139:93-100
61. Sasaki M, Ozawa Y, Kurihara T, Kubota S, Yuki K, Noda K, Kobayashi S, Ishida S, Tsubota K: Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia 2010;53:971-979
62. Abe T, Wakusawa R, Seto H, Asai N, Saito T, Nishida K: Topical doxycycline can induce expression of BDNF in transduced retinal pigment epithelial cells transplanted into the subretinal space. Invest Ophthalmol Vis Sci 2008;49:3631-3639